OxyContin is the brand-name, extended-release (ER) oral formulation of oxycodone hydrochloride. It is classified as a Schedule II controlled substance. Like generic oxycodone ER formulations, this brand-specific tablet delivers a potent amount of medication meant to be released slowly over a prolonged period Because of its strength, OxyContin is strictly indicated only for patients who are already opioid-tolerant and require continuous management of severe, chronic pain (such as advanced cancer pain) The Hazard: Counterfeit versions of branded OxyContin have been intercepted. Laboratory testing confirmed that these fake tablets contain zero oxycodone; instead, they are contaminated with lethal, synthetic nitazene compounds (such as metonitazene and isotonitazene The "Do Not Alter" Rule: The tablet must be swallowed entirely whole. Never break, crush, chew, or dissolve an OxyContin tablet. Altering the tablet completely destroys its controlled-release matrix, resulting in a phenomenon known as "dose dumping" where the full amount of oxycodone enters the bloodstream at once, which is frequently fatal OxyContin carries a profound risk of addiction, physical dependency, and opioid use disorder (OUD), even when administered under strict medical protocols Severe, chronic constipation
• Nausea and vomiting
• Significant drowsiness or fatigue
• Dizziness or lightheadedness
• Severe skin itching (pruritus)
• Intense sweating or headaches • Respiratory depression (dangerously slow or shallow breathing)
• Inability to wake up or extreme somnolence
• Bluish or pale skin, lips, or fingernails
• Severe low blood pressure (feeling faint or passing out)
• Swelling of the lips, tongue, or throat (allergic reaction)